Phase I Study to Investigate Pharmacodynamics of CJ-12420 Compared to Dexlansoprazole With Evening Dosing

Trial Profile

Phase I Study to Investigate Pharmacodynamics of CJ-12420 Compared to Dexlansoprazole With Evening Dosing

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Tegoprazan (Primary) ; Dexlansoprazole
  • Indications Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux
  • Focus Pharmacodynamics
  • Sponsors CJ HealthCare
  • Most Recent Events

    • 09 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top